FDA Drug recall D-0088-2024
Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc
- FDA Drug
- Class III
- ongoing
- Published 2023-11-15
On 2023-11-15 the FDA classified a Class III recall of Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc by Abbvie, citing labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0088-2024 |
| Classification | Class III |
| Status | ongoing |
| Initiated | 2023-10-17 |
| Published | 2023-11-15 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Abbvie |
| Distribution | n/a |
Product
Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11
Reason
Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.
Identifiers
| ndc | 0074-4341-13 |
|---|---|
| ndc | 0074-4341-90 |
| ndc | 0074-4341-19 |
| ndc | 0074-4341-72 |
| ndc | 0074-4552-13 |
| ndc | 0074-4552-90 |
| ndc | 0074-4552-19 |
| ndc | 0074-4552-11 |
| ndc | 0074-4552-71 |
| ndc | 0074-4552-72 |
| ndc | 0074-5182-13 |
| ndc | 0074-5182-90 |
| ndc | 0074-5182-71 |
| ndc | 0074-5182-19 |
| ndc | 0074-5182-11 |
| ndc | 0074-5182-72 |
| ndc | 0074-6594-13 |
| ndc | 0074-6594-90 |
| ndc | 0074-6594-71 |
| ndc | 0074-6594-19 |
| ndc | 0074-6594-72 |
| ndc | 0074-6624-13 |
| ndc | 0074-6624-90 |
| ndc | 0074-6624-19 |
| ndc | 0074-6624-11 |
| ndc | 0074-6624-71 |
| ndc | 0074-6624-72 |
| ndc | 0074-9296-13 |
| ndc | 0074-9296-90 |
| ndc | 0074-9296-19 |
| ndc | 0074-9296-71 |
| ndc | 0074-9296-72 |
| ndc | 0074-7068-13 |
| ndc | 0074-7068-90 |
| ndc | 0074-7068-71 |
| ndc | 0074-7068-19 |
| ndc | 0074-7068-11 |
| ndc | 0074-7068-72 |
| ndc | 0074-3727-13 |
| ndc | 0074-3727-90 |
| ndc | 0074-3727-71 |
| ndc | 0074-3727-19 |
| ndc | 0074-3727-72 |
| ndc | 0074-7069-90 |
| ndc | 0074-7069-71 |
| ndc | 0074-7069-19 |
| ndc | 0074-7069-11 |
| ndc | 0074-7069-72 |
| ndc | 0074-7070-13 |
| ndc | 0074-7070-90 |
| ndc | 0074-7070-71 |
| ndc | 0074-7070-19 |
| ndc | 0074-7070-72 |
| ndc | 0074-7148-90 |
| ndc | 0074-7148-19 |
| ndc | 0074-7148-71 |
| ndc | 0074-7148-11 |
| ndc | 0074-7148-72 |
| ndc | 0074-7149-90 |
| ndc | 0074-7149-19 |
| code_info | Lot # 1187435 exp date: 02/2024 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0088-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.